AT301766B - Verfahren zur Herstellung von neuen 9α-unsubstituierten 11β-Chlor-19-nor-steroiden - Google Patents

Verfahren zur Herstellung von neuen 9α-unsubstituierten 11β-Chlor-19-nor-steroiden

Info

Publication number
AT301766B
AT301766B AT706867A AT706867A AT301766B AT 301766 B AT301766 B AT 301766B AT 706867 A AT706867 A AT 706867A AT 706867 A AT706867 A AT 706867A AT 301766 B AT301766 B AT 301766B
Authority
AT
Austria
Prior art keywords
steroids
unsubstituted
chloro
new
production
Prior art date
Application number
AT706867A
Other languages
English (en)
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Application granted granted Critical
Publication of AT301766B publication Critical patent/AT301766B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT706867A 1966-07-29 1967-07-28 Verfahren zur Herstellung von neuen 9α-unsubstituierten 11β-Chlor-19-nor-steroiden AT301766B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3427566 1966-07-29
GB23066/67A GB1202521A (en) 1966-07-29 1966-07-29 01beta-CHLORO-19-NOR-STEROIDS

Publications (1)

Publication Number Publication Date
AT301766B true AT301766B (de) 1972-09-25

Family

ID=26256295

Family Applications (2)

Application Number Title Priority Date Filing Date
AT851569A AT311564B (de) 1966-07-29 1967-07-28 Verfahen zur Herstellung von neuen in 9α-Stellung unsubstituierten 6,11β-Dichlor-19-norsteroid-4-en (bzw. 4,6-dien)-3-onen
AT706867A AT301766B (de) 1966-07-29 1967-07-28 Verfahren zur Herstellung von neuen 9α-unsubstituierten 11β-Chlor-19-nor-steroiden

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT851569A AT311564B (de) 1966-07-29 1967-07-28 Verfahen zur Herstellung von neuen in 9α-Stellung unsubstituierten 6,11β-Dichlor-19-norsteroid-4-en (bzw. 4,6-dien)-3-onen

Country Status (12)

Country Link
JP (2) JPS5021469B1 (de)
AT (2) AT311564B (de)
BE (1) BE702023A (de)
CH (2) CH580644A5 (de)
DE (1) DE1668124B2 (de)
DK (2) DK129004B (de)
FR (2) FR1565340A (de)
GB (1) GB1202521A (de)
IL (1) IL28411A (de)
NL (1) NL6710459A (de)
PL (1) PL79253B1 (de)
SE (2) SE349025B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1289521A (de) * 1969-01-23 1972-09-20
GB1313659A (en) * 1969-07-25 1973-04-18 Glaxo Lab Ltd 9alpha-unsubstituted-11beta-chloro-19-norpregnane compounds
JPS5090183A (de) * 1973-12-14 1975-07-19
JPS5090184A (de) * 1973-12-14 1975-07-19

Also Published As

Publication number Publication date
SE350488B (de) 1972-10-30
BE702023A (de) 1968-01-29
AT311564B (de) 1973-11-26
JPS5224013B1 (de) 1977-06-28
DE1668124A1 (de) 1971-05-06
DK131295B (da) 1975-06-23
CH584724A5 (de) 1977-02-15
DK129004B (da) 1974-08-05
FR1565340A (de) 1969-05-02
DK131295C (de) 1975-11-17
CH580644A5 (de) 1976-10-15
GB1202521A (en) 1970-08-19
DE1668124B2 (de) 1976-10-07
SE349025B (de) 1972-09-18
NL6710459A (de) 1968-01-30
FR7812M (de) 1970-05-20
JPS5021469B1 (de) 1975-07-23
PL79253B1 (de) 1975-06-30
IL28411A (en) 1972-07-26

Similar Documents

Publication Publication Date Title
AT279599B (de) Verfahren zur herstellung von neuen 3-furylmethanolen
CH501599A (de) Verfahren zur Herstellung von neuen Amidinoharnstoffen
AT270866B (de) Verfahren zur Herstellung von neuen Penicillinen
AT277475B (de) Verfahren zur herstellung von neuen n6-aralkyl-adenosinderivaten
AT272528B (de) Verfahren zur Herstellung von neuen Adenosin-Derivaten
AT281782B (de) Verfahren zur Herstellung von neuen Polyäthern
AT268682B (de) Verfahren zur Herstellung von neuen Copolyestern
AT273073B (de) Verfahren zur Herstellung von neuen Sulfonen
AT277964B (de) Verfahren zur Herstellung von neuen Ketonitrilen
CH494767A (de) Verfahren zur Herstellung von neuen Pteridinen
AT282059B (de) Verfahren zur Herstellung von neuen Penicillinen
AT272316B (de) Verfahren zur Herstellung von neuen γ-Resorcylsäureaniliden
CH493547A (de) Verfahren zur Herstellung von neuen Pteridinen
AT269485B (de) Verfahren zur Herstellung von neuen Polyhydantoinen
AT276421B (de) Verfahren zur Herstellung von neuen 4-Alkoxy-propylenharnstoff-bzw. -thioharnstoffderivaten
AT281282B (de) Verfahren zur Herstellung von neuen Penicillinen
AT278035B (de) Verfahren zur Herstellung von neuen Benzodioxan-N-methylcarbamaten
AT323754B (de) Verfahren zur herstellung von neuen thiobenzoylaminoalkylbenzolsulfonylharnstoffen
AT279813B (de) Verfahren zur Herstellung von neuen 3β-Formoxy-15α-halogen-14β-hydroxy-5β-card-20(22)-enoliden
AT272363B (de) Verfahren zur Herstellung von neuen Thiosemicarbazonen
CH475973A (de) Verfahren zur Herstellung von neuen Polyepoxiden
CH484103A (de) Verfahren zur Herstellung von neuen Carbamaten
CH487902A (de) Verfahren zur Herstellung von neuen Chinazolinonen
AT269383B (de) Verfahren zur Herstellung von neuen Steroido-oxazolinen
AT271757B (de) Verfahren zur Herstellung von neuen Nitroöstratrienen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee